ATI PHARMACOLOGY PROCTORED EXAM
2025/2026 BANK FORM A B AND C
ACCURATE ACTUAL EXAM WITH
FREQUENTLY TESTED QUESTIONS AND
STUDY GUIDE / EXPERT VERIFIED FOR
GUARANTEED PASS/WELL RESEARCHED
ALREADY GRADED A+
A health care professional is caring for a patient who is
about ot begin alteplase (Activase) therapy to treat
pulmonary embolism. Which of the following drugs should
the health care professional have available in the event of
a severe adverse reaction?
1
,a) Vitamin K
b) Aminocaproic acid (Amicar)
c) Protamine
d) Deferoxamine (Deseferal)
b) Aminocaproic acid (Amicar)
A health care professional is caring for a patient who is
about to begin taking asprin (Ecotrin) to reduce the risk of
a cardiovascular event. The health care professional should
understand that the drug inhibits platelet aggregation by
which of the following mechanisms?
a) Activating thromboxane A2
b) Blocking adenosine diphosphate receptor agonists
c) Supressing specific clotting factors
d) Inhibiting cyclooxygenase action in platelets
d) Inhibiting cyclooxygenase action in platelets
A health care professional is caring for a patient who is
about to begin taking oprelvekin (Neumega). The health
care professional should explain to the patient that the
drug has which of the following effects?
a) Stimulates leukocyte maturation
b) Causes myelosupression
2
,c) Increases platelet production
d) Destroys blood clots
c) Increases platelet production
A health care professional is preparing to administer the
prescribed dose of filgrastim (Neupogen) to a patient. The
patient's laboratory results indicate that the patient has a
WBC count of 12,000 mm3. Which of the following actions
should the health care professional take?
a) Clarify the prescription within the provider.
b) Administer the drug with an analgesic
c) Limit venipunctures
d) Assess breath sounds
a) Clarify the prescription within the provider.
A health care professional is caring for a patient who is
about to begin taking ferrous sulfate (Feosol) to treat iron-
deficiency anemia. When talking with the patient about
the drug, the health care professional should include which
of the following instructions? (Select all that apply)
a) Eat iron-enriched foods
b) Spread the dosage across each day
c) Take the drug on an empty stomach
d) Report dark green or black stools
e) Increase dietary fiber intake
3
, a) Eat iron-enriched foods
b) Spread the dosage across each day
c) Take the drug on an empty stomach
d) Increase dietary fiber intake
A health care professional is caring for a patient who is
about to begin iron dextran (INFeD) therapy. When
administering the drug IM, the health care professional
should take which of the following actions? (Select all that
apply)
a) Administer a test dose
b) Monitor blood pressure
c) Have epinephrine available
d) Premedicate with atropine
e) Use the Z-track technique
a) Administer a test dose
b) Monitor blood pressure
c) Have epinephrine available
d) Use the Z-track technique
A patient is about to begin therapy with recombinant
factor IX (BeneFix) to treat hemophilia B. The patient
asks the health care professional about the risk of disease
transmission with recombinant factor IX, as compared
with plasma-derived factor IX. The health care
professional should explain that recombinant factor IX
4
2025/2026 BANK FORM A B AND C
ACCURATE ACTUAL EXAM WITH
FREQUENTLY TESTED QUESTIONS AND
STUDY GUIDE / EXPERT VERIFIED FOR
GUARANTEED PASS/WELL RESEARCHED
ALREADY GRADED A+
A health care professional is caring for a patient who is
about ot begin alteplase (Activase) therapy to treat
pulmonary embolism. Which of the following drugs should
the health care professional have available in the event of
a severe adverse reaction?
1
,a) Vitamin K
b) Aminocaproic acid (Amicar)
c) Protamine
d) Deferoxamine (Deseferal)
b) Aminocaproic acid (Amicar)
A health care professional is caring for a patient who is
about to begin taking asprin (Ecotrin) to reduce the risk of
a cardiovascular event. The health care professional should
understand that the drug inhibits platelet aggregation by
which of the following mechanisms?
a) Activating thromboxane A2
b) Blocking adenosine diphosphate receptor agonists
c) Supressing specific clotting factors
d) Inhibiting cyclooxygenase action in platelets
d) Inhibiting cyclooxygenase action in platelets
A health care professional is caring for a patient who is
about to begin taking oprelvekin (Neumega). The health
care professional should explain to the patient that the
drug has which of the following effects?
a) Stimulates leukocyte maturation
b) Causes myelosupression
2
,c) Increases platelet production
d) Destroys blood clots
c) Increases platelet production
A health care professional is preparing to administer the
prescribed dose of filgrastim (Neupogen) to a patient. The
patient's laboratory results indicate that the patient has a
WBC count of 12,000 mm3. Which of the following actions
should the health care professional take?
a) Clarify the prescription within the provider.
b) Administer the drug with an analgesic
c) Limit venipunctures
d) Assess breath sounds
a) Clarify the prescription within the provider.
A health care professional is caring for a patient who is
about to begin taking ferrous sulfate (Feosol) to treat iron-
deficiency anemia. When talking with the patient about
the drug, the health care professional should include which
of the following instructions? (Select all that apply)
a) Eat iron-enriched foods
b) Spread the dosage across each day
c) Take the drug on an empty stomach
d) Report dark green or black stools
e) Increase dietary fiber intake
3
, a) Eat iron-enriched foods
b) Spread the dosage across each day
c) Take the drug on an empty stomach
d) Increase dietary fiber intake
A health care professional is caring for a patient who is
about to begin iron dextran (INFeD) therapy. When
administering the drug IM, the health care professional
should take which of the following actions? (Select all that
apply)
a) Administer a test dose
b) Monitor blood pressure
c) Have epinephrine available
d) Premedicate with atropine
e) Use the Z-track technique
a) Administer a test dose
b) Monitor blood pressure
c) Have epinephrine available
d) Use the Z-track technique
A patient is about to begin therapy with recombinant
factor IX (BeneFix) to treat hemophilia B. The patient
asks the health care professional about the risk of disease
transmission with recombinant factor IX, as compared
with plasma-derived factor IX. The health care
professional should explain that recombinant factor IX
4
